The Last Project

Somewhere before the sun is up, a person who is not sick stands in a cold bathroom and goes to work on the body. A pinch of skin at the waist, a capped pen pressed flat, a click. Then the scale. Then the ring on the finger, read for the quality of last night's sleep. The powder stirred into a glass, the capsules counted by hand into a small dish. None of it is treatment. No one is dying, and no one wrote a prescription for the morning. It is maintenance on the one machine you did not choose and cannot trade in, carried out with the seriousness earlier people saved for prayer.

The body is the single thing you were handed without a receipt. You can change your name, your city, your work, your god, and most people now change all four at least once. The body came stapled to the ticket, and it was always going to leave when the ride was over. For as long as there have been people, some of them have refused that arrangement, and the refusal has a long and mostly humiliating history. Emperors swallowed mercury because a wise man swore it would make them last. Alchemists died younger than the peasants they looked down on, chasing the compound that would stop death. The men who funded the search are labeled boxes of dust in museum basements. The wish outlived every one of them.

Here is what is new, and it is the only thing that is new. The oldest wish finally has a supply chain. When the self becomes the highest thing a person can be, and the feed is arranged and the wardrobe is arranged and the apartment and the résumé and the face are all arranged for the audience, attention turns to the one raw material still unfinished. The self as the last project. A wish is something you carry to the grave. A project is something you can be sold the tools for, one quarter at a time.

Start with the pen. In a year and a half, the share of American adults using one of the new appetite drugs went from six in a hundred to twelve.¹ Something almost no one had heard of became something one in eight was doing. It is easy to file that under vanity, or under health, and miss what actually moved. What moved was a belief. The body stopped being a fate you were dealt and became a setting you could change, this week, with a decision and a copay. Once a person believes that about their own flesh, they do not go back to believing the old thing.

The person at the sink does not think of themselves as a market. The people who make the pen do. One company's two drugs in this single category cleared roughly thirty-six and a half billion dollars in a year.² That is not the revenue of a medicine. That is the revenue of a very old wish that finally found a molecule to attach itself to. And a wish that size does not sit still. It looks around the body for the next thing that could be adjusted.

There is a wrinkle the pitch decks skip. Of the people who start, roughly half or more are gone inside a year. They stop. The weight, often, comes back. So what did they buy, if not the result? They bought the feeling of a body that answers to them, and they paid full price for it. The wanting outran the keeping, which is the tell of every market built on the self. Arriving was never the point. Being, for a season, someone who was doing something about it, that was the point. And what becomes of a person who has felt that once, and lost it, and wants it back?

They keep climbing. The same year, people around the world had something done to their faces and bodies on purpose, by a professional, close to thirty-eight million times.³ This is the same loop reaching skin. A self that has to be displayed, an audience that now grades the face, a grade you can raise by appointment. When the grade can be raised by appointment, an enormous number of people make the appointment. Not one of them believes they are chasing forever. They are only trying to look, this season, a little less like time is winning.

Above the face sits the dashboard. Lie still in a tube for an hour and a machine will read you organ by organ and hand back a full accounting of yourself, at a price that has fallen to four hundred and ninety-nine dollars.⁴ You are not buying a diagnosis. If you were sick you would go to a doctor. You are buying a number, a hundred numbers, a baseline to beat next quarter, proof rendered in biomarkers that you are the sort of person who stays on top of it. The self, at last, with a metrics page. Roll the pens and the appointments and the scans and the powders together and you are looking at one of the largest voluntary habits on the planet.⁵

And all of it, the whole shimmering pile, is still the foothills. Because none of it, not one procedure or subscription, touches the thing people actually flinch from. Looking younger is a stand-in. The want underneath does not care how you look. It cares how much time you get.

You can watch that want come out of hiding in the people who stopped pretending. One man turned his own body into a public laboratory, measured everything a body can be measured for, and named the whole enterprise after the only outcome that mattered to him: don't die.⁶ Millions followed. He built an audience, then a business on the supplements the audience wanted. And somewhere in all that measuring, his own body handed him a condition the instruments had not seen coming, an autoimmune disorder that the tracking, for all its precision, had not explained. Judge the project however you like. He is doing out loud, with better equipment, what the person at the sink does in the dark. The surprise buried inside his own data is the whole story of this moment, if you are willing to sit with it.

The money agrees the prize is time, though the money is more nervous than it was. Funding for the labs trying to slow or reverse aging came to around five and a half billion dollars in a year, and cooling.⁷ Real capital, steadier heads. Serious people are building serious institutions to attempt a thing no one has ever done, and that is not nothing. It is also not the same as a result, and the distance between the two is what all of this keeps circling.

Here is what genuinely changed under the old sun, the reason this is not just the latest verse of a very old song. The tools got real. The 2024 prize in chemistry went to AI-driven protein science, to software that can read the shape of the machinery of life and design new parts for it from scratch.⁸ For a hundred years the search was a matter of luck and patience. Now some of it is a matter of compute.

Then the promise started to cash. A molecule designed largely by one of these systems became the first of its kind to show a genuine signal of working in living patients, discovered in something like eighteen months.⁹ Discovery on a problem like that used to devour years and fortunes. The machine did not get tired, did not run out of guesses, did not need to sleep. Then it got personal in the most literal way there is. A single sick infant received a gene-editing therapy built for one mutation, theirs, designed and dosed in roughly six months.¹⁰ One child. Made to order. At a speed that would have read as fiction ten years back.

If you read only that half of the ledger, you would think the door was already open. So read the other half. No therapy anywhere on Earth is approved to extend a human life. The regulators who approve medicines do not treat aging itself as a disease, which leaves no finish line to run at and nothing a drug is permitted to claim. The most celebrated of the from-scratch AI drugs, the first one ever put into a person, was quietly shelved after the earliest round of testing.¹¹

And the miracle, measured, is smaller than the headline. The one gene-editing therapy that reached approval treated about sixty-four patients in a year, against tens of thousands who qualified. The future arrived for sixty-four people. Everyone else stayed in line. The hard part sits exactly where the machines do not yet reach. The new tools have compressed discovery, the front of the pipe, the part that was always a contest of ideas. They have barely touched the clinic, where most promising drugs still fail, slowly, on human bodies that refuse to be hurried.¹² The wish has a supply chain now. It does not yet have a product.

So let me be exact about what I am claiming and what I am not. I am not telling you these labs will beat death, or slow it, or that the pen and the scan and the AI-built molecule add up to a single extra year of your life. I do not know that. Nobody does. My bet is narrower, and I think harder to duck. The industry built on not dying is going to become one of the largest on Earth, and it will get there whether or not it works, because it is not priced on results. It is priced on wanting. The other markets sell you attention, or status, or a self to perform. This one sells you the appointment you were always going to keep. It has the entire species for a customer base, and no one in that customer base has ever, in the whole history of wanting, decided they wanted less of it.

This is the one market that reaches all the way to the flesh, and the price it names is what you will trade, and for how long, for the feeling that time answers to you. A great many people will move through it as customers. A very few will own the labs. That gap is not the argument. It is the same old distance, and here it runs through the body itself.

There is one thing, though, that no pen and no scan and no molecule can do for you, however good they get. They can measure you. They cannot keep you company while you are measured. A life spent entirely on the self is a life spent, more and more, alone with it, at the mirror before dawn, reading your own numbers to no one. And the moment a person is that alone with their own project, a very particular kind of company begins to look irresistible. Not the kind that helps you. The kind that never, once, judges what it sees.